Search Results - "Park, Cheol‐Young"

Refine Results
  1. 1

    The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study by Hong, Sangmo, Han, Kyungdo, Park, Cheol-Young

    Published in BMC medicine (25-11-2020)
    “…The triglyceride glucose (TyG) index is an inexpensive clinical surrogate marker for insulin resistance. However, the relationship between TyG index and…”
    Get full text
    Journal Article
  2. 2

    Cooperative Electronic Structure Modulator of Fe Single‐Atom Electrocatalyst for High Energy and Long Cycle Li–S Pouch Cell by Lim, Won‐Gwang, Park, CheolYoung, Jung, Hyeonjung, Kim, Seoa, Kang, Seok Hun, Lee, Young‐Gi, Jeong, Yo Chan, Yang, Seung Bo, Sohn, Kwonnam, Han, Jeong Woo, Lee, Jinwoo

    Published in Advanced materials (Weinheim) (01-03-2023)
    “…High‐energy and long cycle lithium–sulfur (Li–S) pouch cells are limited by the insufficient capacities and stabilities of their cathodes under practical…”
    Get full text
    Journal Article
  3. 3

    The insulin resistance by triglyceride glucose index and risk for dementia: population-based study by Hong, Sangmo, Han, Kyungdo, Park, Cheol-Young

    Published in Alzheimer's research & therapy (05-01-2021)
    “…Insulin resistance is suggested to have negative effects on cognition; however, results from large population studies are lacking. In this study, the potential…”
    Get full text
    Journal Article
  4. 4

    Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial by Moon, Sun Joon, Kim, Kyung‐Soo, Lee, Woo Je, Lee, Mi Yeon, Vigersky, Robert, Park, CheolYoung

    Published in Diabetes, obesity & metabolism (01-01-2023)
    “…Aim To evaluate the efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring (RT‐CGM) system in non‐insulin–treated patients with…”
    Get full text
    Journal Article
  5. 5

    Biomarkers of insulin sensitivity and insulin resistance: Past, present and future by Park, Se Eun, Park, Cheol-Young, Sweeney, Gary

    “…Insulin resistance in insulin target tissues including liver, skeletal muscle and adipose tissue is an early step in the progression towards type 2 diabetes…”
    Get full text
    Journal Article
  6. 6

    Anti-Obesity Drugs: A Review about Their Effects and Safety by Kang, Jun Goo, Park, Cheol-Young

    Published in Diabetes & metabolism journal (01-02-2012)
    “…The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is…”
    Get full text
    Journal Article
  7. 7

    Weight change is significantly associated with risk of thyroid cancer: A nationwide population-based cohort study by Kwon, Hyemi, Han, Kyung-Do, Park, Cheol-Young

    Published in Scientific reports (07-02-2019)
    “…Obesity is a risk factor for many cancers including breast, esophageal, colon, and thyroid cancer. We aimed to evaluate the association of thyroid cancer with…”
    Get full text
    Journal Article
  8. 8

    Predictive Value of Triglyceride Glucose Index for the Risk of Incident Diabetes: A 4-Year Retrospective Longitudinal Study by Lee, Da Young, Lee, Eun Seo, Kim, Ji Hyun, Park, Se Eun, Park, Cheol-Young, Oh, Ki-Won, Park, Sung-Woo, Rhee, Eun-Jung, Lee, Won-Young

    Published in PloS one (28-09-2016)
    “…The Triglyceride Glucose Index (TyG index) is considered a surrogate marker of insulin resistance. The aim of this study is to investigate whether the TyG…”
    Get full text
    Journal Article
  9. 9

    The Incremental Risk of Pancreatic Cancer According to Fasting Glucose Levels: Nationwide Population-Based Cohort Study by Koo, Dong-Hoe, Han, Kyung-Do, Park, Cheol-Young

    “…Abstract Context It has been unclear whether the risk of pancreatic cancer is different according to glucose levels. Objective To determine the association…”
    Get full text
    Journal Article
  10. 10

    Outcomes for Inappropriate Renal Dose Adjustment of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus: Population-Based Study by Hong, Sangmo, Han, Kyungdo, Park, Cheol-Young

    Published in Mayo Clinic proceedings (01-01-2020)
    “…To estimate inappropriate dosing of dipeptidyl peptidase-4 (DPP-4) inhibitors and to assess the risk of emergency department visits, hypoglycemia, and…”
    Get full text
    Journal Article
  11. 11

    Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence by Moon, Sun Joon, Jung, Inha, Park, Cheol-Young

    Published in Diabetes & metabolism journal (01-11-2021)
    “…Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose…”
    Get full text
    Journal Article
  12. 12

    Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study by Hyun, Young Youl, Kim, Kyung‐Soo, Hong, Sangmo, Han, Kyungdo, Park, CheolYoung

    Published in Diabetes, obesity & metabolism (01-10-2024)
    “…Aim Previous studies have shown that fenofibrate improves outcomes such as albuminuria and estimated glomerular filtration rate decline. We hypothesize that…”
    Get full text
    Journal Article
  13. 13

    Peripartum Management of Gestational Diabetes Using a Digital Health Care Service: A Pilot, Randomized Controlled Study by Sung, Ji-Hee, Lee, Da Young, Min, Kyoung Pil, Park, Cheol-Young

    Published in Clinical therapeutics (01-11-2019)
    “…The prevalence of gestational diabetes mellitus (GDM) is increasing, and multifaceted interventions are effective in the management of GDM. This study aimed to…”
    Get full text
    Journal Article
  14. 14

    Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation by Won, Jong Chul, Park, Cheol-Young, Oh, Sang Woo, Lee, Eon Sook, Youn, Byung-Soo, Kim, Min-Seon

    Published in PloS one (30-07-2014)
    “…Obesity and insulin resistance are hallmarks of the metabolic syndrome, which is associated with low-grade chronic inflammation. Clusterin/apolipoprotein J is…”
    Get full text
    Journal Article
  15. 15

    Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials by Lyu, Young Sang, Hong, Sangmo, Lee, Si Eun, Cho, Bo Young, Park, Cheol-Young

    Published in Cardiovascular diabetology (15-02-2024)
    “…We assessed the efficacy and safety of enavogliflozin (0.3 mg), a newly developed SGLT-2 inhibitor, in patients with type 2 diabetes mellitus based on kidney…”
    Get full text
    Journal Article
  16. 16

    Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis by Lee, Yong Ho, Cho, Yongin, Lee, Byung Wan, Park, Cheol Young, Lee, Dae Ho, Cha, Bong Soo, Rhee, Eun Jung

    Published in Diabetes & metabolism journal (01-02-2019)
    “…Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to…”
    Get full text
    Journal Article
  17. 17

    Metabolomic and lipidomic analysis of the effect of pioglitazone on hepatic steatosis in a rat model of obese Type 2 diabetes by Yang, Hyekyung, Suh, Dong Ho, Kim, Dae Hee, Jung, Eun Sung, Liu, Kwang‐Hyeon, Lee, Choong Hwan, Park, CheolYoung

    Published in British journal of pharmacology (01-09-2018)
    “…Background and Purpose Thiazolidinediones, acting as PPAR‐γ ligands, reduce hepatic steatosis in humans and animals. However, the underlying mechanism of this…”
    Get full text
    Journal Article
  18. 18

    Triglyceride and glucose index is a simple and easy‐to‐calculate marker associated with nonalcoholic fatty liver disease by Kim, Kyung‐Soo, Hong, Sangmo, Ahn, Hong‐Yup, Park, CheolYoung

    Published in Obesity (Silver Spring, Md.) (01-06-2022)
    “…Objective The aim of this study was to evaluate the relationship between the triglyceride and glucose (TyG) index and nonalcoholic fatty liver disease (NAFLD)…”
    Get full text
    Journal Article
  19. 19

    Background and data configuration process of a nationwide population-based study using the korean national health insurance system by Song, Sun Ok, Jung, Chang Hee, Song, Young Duk, Park, Cheol-Young, Kwon, Hyuk-Sang, Cha, Bong Soo, Park, Joong-Yeol, Lee, Ki-Up, Ko, Kyung Soo, Lee, Byung-Wan

    Published in Diabetes & metabolism journal (01-10-2014)
    “…The National Health Insurance Service (NHIS) recently signed an agreement to provide limited open access to the databases within the Korean Diabetes…”
    Get full text
    Journal Article
  20. 20

    Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study by Hwang, You‐Cheol, Ahn, Hong‐Yup, Park, CheolYoung

    Published in Obesity (Silver Spring, Md.) (01-08-2019)
    “…Objective It was hypothesized that the presence of nonalcoholic fatty liver disease (NAFLD) at baseline predicts future conversion from the metabolically…”
    Get full text
    Journal Article